-
P385551-2mgPaxillinol acts as a negative control for the maxi-K channel inhibitor paxilline (50% block at 0.1-1 μM)1.
-
P133027-1gapplication:Pazufloxacin Mesylate (T-3762, Pazucross), also known as Pazucross and T-3762, is a quinolone antibacterial agent used for the intravenous therapy of several infections.
-
P133027-25gapplication:Pazufloxacin Mesylate (T-3762, Pazucross), also known as Pazucross and T-3762, is a quinolone antibacterial agent used for the intravenous therapy of several infections.
-
P133027-5gapplication:Pazufloxacin Mesylate (T-3762, Pazucross), also known as Pazucross and T-3762, is a quinolone antibacterial agent used for the intravenous therapy of several infections.
-
P329598-1mgPC-766B is a 16-membered macrolide antibiotic produced by Nocardia brasiliensis, reported by researchers at Sumitomo in 1993. Structurally, PC-766B is a member of bafilomycin class, featuring a rare butadiene side-chain. PC-766B is active against
-
P648408-10mgPD 404182 is a potent and competitive inhibitor of human dimethylarginine dimethylaminohydrolase 1 (DDAH1) , with an IC 50 of 9 μM. PD 404182 exhibits antiangiogenic and antiviral activity in vitroIn VitroPD 404182 (20 μM) increases asymmetric
-
P648408-25mgPD 404182 is a potent and competitive inhibitor of human dimethylarginine dimethylaminohydrolase 1 (DDAH1) , with an IC 50 of 9 μM. PD 404182 exhibits antiangiogenic and antiviral activity in vitroIn VitroPD 404182 (20 μM) increases asymmetric
-
P648408-50mgPD 404182 is a potent and competitive inhibitor of human dimethylarginine dimethylaminohydrolase 1 (DDAH1) , with an IC 50 of 9 μM. PD 404182 exhibits antiangiogenic and antiviral activity in vitroIn VitroPD 404182 (20 μM) increases asymmetric
-
P648408-5mgPD 404182 is a potent and competitive inhibitor of human dimethylarginine dimethylaminohydrolase 1 (DDAH1) , with an IC 50 of 9 μM. PD 404182 exhibits antiangiogenic and antiviral activity in vitroIn VitroPD 404182 (20 μM) increases asymmetric
-
P655418-1mlPD 404182 is a potent and competitive inhibitor of human dimethylarginine dimethylaminohydrolase 1 (DDAH1) , with an IC 50 of 9 μM. PD 404182 exhibits antiangiogenic and antiviral activity in vitroIn VitroPD 404182 (20 μM) increases asymmetric
-
P102019-100gPefloxacin mesylate dihydrate.
-
P102019-1gPefloxacin mesylate dihydrate.